1-204944335-C-T
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 3P and 4B. PM2PP2BP4_Strong
The NM_001005388.3(NFASC):c.20C>T(p.Pro7Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000161 in 1,613,674 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001005388.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NFASC | NM_001005388.3 | c.20C>T | p.Pro7Leu | missense_variant | 3/30 | ENST00000339876.11 | |
NFASC | NM_001160331.2 | c.20C>T | p.Pro7Leu | missense_variant | 2/28 | ENST00000539706.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NFASC | ENST00000339876.11 | c.20C>T | p.Pro7Leu | missense_variant | 3/30 | 5 | NM_001005388.3 | ||
NFASC | ENST00000539706.6 | c.20C>T | p.Pro7Leu | missense_variant | 2/28 | 5 | NM_001160331.2 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152216Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000361 AC: 9AN: 249420Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 134978
GnomAD4 exome AF: 0.0000164 AC: 24AN: 1461458Hom.: 0 Cov.: 32 AF XY: 0.0000179 AC XY: 13AN XY: 726986
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152216Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74362
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 25, 2023 | The c.20C>T (p.P7L) alteration is located in exon 3 (coding exon 1) of the NFASC gene. This alteration results from a C to T substitution at nucleotide position 20, causing the proline (P) at amino acid position 7 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at